-transparent.png){kind=logo}
Fourteen schizophrenic subjects were evaluated for degree of psychosis before and after treatment with the antipsychotic drug haloperidol and for plasma homovanillic acid concentration after four and 28 days of treatment. A significant correlation was found between an increase in homovanillic acid concentration on day 4 or a decrease from day 4 to day 28 and the degree of improvement after four weeks of treatment. Thus, those patients who had the greatest change in plasma homovanillic acid in response to neuroleptic blockade showed the greatest improvement. These and other observations have led us to propose that the central dopaminergic system, through adaptive changes in activity, serves as a physiologic buffer system protecting against destabilization of mental function from diverse biologic or psychologic insults.
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
January 1989,
Psychopharmacology bulletin,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
September 1991,
Biological psychiatry,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
June 1984,
Biological psychiatry,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
January 1992,
Clinical neuropharmacology,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
January 1987,
Psychopharmacology series,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
January 1985,
Psychopharmacology,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
August 1995,
Biological psychiatry,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
September 2000,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
March 1984,
European journal of pharmacology,
R Davila, and
E Manero, and
M Zumarraga, and
I Andia, and
J W Schweitzer, and
A J Friedhoff
October 1993,
Schizophrenia research,
